Last $5.28 USD
Change Today +0.22 / 4.35%
Volume 58.3K
SRNE On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Scott Salka

Former Chief Executive Officer and Director, Ambit Biosciences Corporation
AgeTotal Calculated CompensationThis person is connected to 20 board members in 1 different organizations across 3 different industries.

See Board Relationships
52--

Background*

Mr. Michael Scott Salka serves as Chief Executive Officer of Aspyrian, CendR, and Vesper Biologics, all biotechnology companies. Mr. Salka served as Chief Executive Officer of Ambit Biosciences Corporation from 2001 to 2010. Mr. Salka Co-Founded Sequana Therapeutics, Inc. in early 1993. He served as Chief Financial Officer of Sequana Therapeutics Inc. since September 1995 and also served as its Vice President - Operations. Mr. Salka played key roles in financing it through ...

Read Full Background

Corporate Headquarters*

6042 Cornerstone Ct. West
San Diego, California 92121

United States

Phone: 858-210-3700
Fax: 858-210-3759

Board Members Memberships*

Former Chief Executive Officer and Director
Director
2012-2014
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Science Committee

Education*

MBA
Carnegie Mellon University
BS
San Diego State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRNE:US $5.28 USD +0.22

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SORRENTO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.